Together, the Lyme IgG and IgM motif panels exhibited an 87.8% (95% confidence interval [CI], 83.5 to 92.1%; 195/222) positive agreement to STTT in the Lyme disease discovery cohort (Fig. 3). This evidence concerns the gene CD40LG and Lyme disease.